Back to Search
Start Over
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD)
- Publication Year :
- 2017
-
Abstract
- This document presents the guidelines for anti-aquaporin-4 (AQP4) antibody testing that has been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Essential clinical information on neuromyelitis optica spectrum disorders, indications and limits of anti-AQP4 antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists.
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Anti-aquaporin-4 antibodies
Anti-myelin oligodendrocyte glycoprotein antibodies
Cell-based assay
Laboratory diagnostics
Neurological autoimmune diseases
Neurology
education
Dermatology
Anti-aquaporin-4 antibodie
Antibodies
03 medical and health sciences
0302 clinical medicine
Laboratory diagnostic
Clinical information
medicine
Humans
Medical physics
Anti-myelin oligodendrocyte glycoprotein antibodie
Aquaporin 4
Neuromyelitis optica
business.industry
Neuromyelitis Optica
General Medicine
medicine.disease
Psychiatry and Mental health
030104 developmental biology
Anti aquaporin 4 antibody
Neuromyelitis Optica Spectrum Disorders
Immunology
Neurology (clinical)
business
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....a923abd5d507bb5613483e1dfbc2b0d3